Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker
Novartis' heart-failure drug fails in clinical trial; Sanofi, Regeneron file Dupixent patent suit; FDA approves Newron's Xadago for PD
A new report analyzing gender parity in advertising found that men tend to endorse other men at higher rates than women. Execs share their insights about the issue.
A Pfizer poll shows patients rely on over-the-counter medications but need help finding the right treatment.
The drugmaker and patient network teamed up to establish a formal framework for deploying activity trackers for patients with MS and for capturing that data.
A small physician survey shows doctors think their patients have higher adherence rates than the norm.
Despite hurdles of practitioner buy-in and legacy IT, value-based care is on pace to overtake fee-for-service.
Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.
A report published by JAMA indicated that online reviews sway a percentage of patients, but that personal recommendations hold more weight.
The third lifestyle survey shows that doctors are battling the bulge just like everyone else.
A poll indicates new cholesterol guidelines won't shake up the statin market in 2014.
A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.
A good percentage of consumers are open to visiting a pharmaceutical company website, an online survey shows, despite a persistent undercurrent of distrust for industry.
Sales may be rising, but a new study finds current psoriasis therapies leave room for improvement. Over half of patients said they want better options.
Researchers say we've been overestimating how many NPs and PAs can be expected to ease the inflow of just-insured patients, while another study shows just why they may be bypassing independent practices.
A new survey of doctors reveals how much they know (or don't) about the looming launch of healthcare exchanges.
Publisher UBM spurs medical competition among psychiatrists, Bayer says it's keeping its diabetes division.
An analysis of a cross-section of the pharma industry shows budgets of pharmaceutical marketing research teams are starting to recover from 2008 lows.
Only 35% of physicians are aware of the FDA's class-wide safety plan for certain opioids, a survey showed, suggesting an awareness challenge as the plan gets under way.
MM&M's 26th annual Career & Salary Survey is now open. Help us to give you the truest picture of salaries, opportunities, migration, aspirations and opinions within pharma and healthcare marketing.
Doctors responding to an MM&M survey hosted by Sermo - a social network for practicing physicians - said they use the Epocrates mobile app more often for work purposes than any other app.
Primary care physicians gave GlaxoSmithKline sales reps the highest marks on a quality scale, according to an SDI study. The higher physician ratings corresponded with a 12% decline in the number of sales calls GSK reps made to PCPs.
Patients taking a medication and looking online for health information tend to avoid pharmaceutical company sites, according to an online survey conducted by Accenture.
Online drug ads are significantly more helpful this year, particularly with respect to side effect and safety information, according to an About.com survey of its users.
Physicians going online (via computer) for health information visit professional sites most often, and they visit WebMD's Medscape -- a free portal for physicians -- more than any other, according to a comScore/ImpactRx study.
Consumers want more help from their doctors in finding relevant health information on the web, but their doctors are often failing to deliver, according to new research by consumer engagement specialist Kyp and Opinion Research Corporation.
Despite recent FDA missives regarding pharma-sponsored educational sites, consumers want condition awareness information from drugmakers, including a link to the brand, a Manhattan Research study found.
Marketers working on Pfizer brands Viagra and Chantix, and AstraZeneca's Nexium, can pat themselves on the back, since they all scored in the "genius" percentile based on digital marketing competency, according to the L2 Digital IQ Index.
Even when factors like education level, income and age are accounted for, adults with chronic diseases are still less likely to go online or have internet access, compared with other adults, according to a Pew report.
Just 35% of the individuals surveyed by About.com in June said they would fill a prescription on doctor's orders after a diagnosis, without first doing research online.
- Five things for pharma marketers to know: Monday, April 24, 2017
- Five things for pharma marketers to know: Thursday, April 20, 2017
- Five things for pharma marketers to know: Friday, April 21, 2017
- Five things for pharma marketers to know: Tuesday, April 25, 2017
- Five things for pharma marketers to know: Wednesday, April 26, 2017
- How pharma marketers are using behavioral science
- Veeva and QuintilesIMS tussle over customer reference data
- Genentech urges broader adoption of value-based payment models
- Some brands thought to shift online ad dollars, creating uncertainty for WebMD
- Study: Medical-marijuana laws lower prescription drug usage